Pfizer Korea’s direct dealing to hit Zuellig Korea

Pfizer Korea’s recent decision to make a direct dealing with Dongwon Phama Group will deal the hardest hit to future business of Zuellig Pharma Korea (ZPK).

Sources say other outsourcing partners, such as MSD Korea, BMS Korea, will follow suit right after Pfizer Korea.

The Korea Association of Pharmaceutical Wholesaler (KAPW) predicted a number of other multinational companies will embar...